The objective of this research is to enhance understanding of the regulation of erthropoiesis. We have developed a culture system in which the addition of the Friend polycythemia virus to murine marrow cells in vitro leads to erythroid bursts in 5 days. A variant virus (FVA) produces bursts in vitro, but these have a marked deficiency of hemoglobin and other late maturation proteins. When erythropoietin (Ep) is added to FVA bursts, it initiates synthesis of hemoglobin and the other proteins. The FVA erythroid bursts (FVA-cells) can be plucked from the cultures and provide highly enriched (90%) Ep-responsive cells with which to study the action of Ep. We now propose to enhance harvest of FVA-cells by completing application of mechanical procedures including buoyant density sedimentation, adherence to plastic, growth of FVA-cells in low calcium medium to retard leukocyte growth and """"""""panning"""""""" using lgG attachment to Fc-receptors and monoclonal antibody to granulocytes-monocytes. FVA-cells are arrested in growth after 5 days in vitro. Velocity sedimentation at unit gravity will be used to separate these cells on the basis of size which is directly related to cell cycle. The stages and length of cell cycle will be measured using 3H thymidine and flow cytometry. The effect of EP on the initiation of cell cycle, duration of each phase of the cell cycle and number of cell cycles will be determined. The precise time at which Ep initiates the onset of hemoglobin synthesis and cellular 59Fe uptake in FVA-cells and the effect of EP on the number, affinity, endocytosis, and intracellular pools of transferrin receptors will be assessed, as well as the effect on the ferritin-59Fe pool, ferritin synthesis and turnover. The effect of EP on the number and affinity of Beta-adrenergic receptors of FVA-cells also will be measured. Once the onset of these markers of Ep effect have been mapped, their appearance will be studied in relation to the different phases of cell cycle of synchronized FVA-cells. By administering short limited pulses of EP we will determine if the hormone is predominantly effective during one phase of the cell cycle. The effect of cell cycle on the time of onset of expression of these hormone induced events as well as on their magnitude will be studied. Finally, the effect of EP on protein kinase activity of FVA-cells will be measured. These studies will enhance our knowledge of the events that are controlled by EP and the relation of this control to the stages of cell cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK015555-17
Application #
3225407
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1974-10-01
Project End
1989-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
17
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Zhao, Zhizhuang Joe; Vainchenker, William; Krantz, Sanford B et al. (2005) Role of tyrosine kinases and phosphatases in polycythemia vera. Semin Hematol 42:221-9
Dai, Chunhua; Chung, Ik-Joo; Krantz, Sanford B (2004) In human immature BFU-E tumor necrosis factor-alpha not only downregulates CDK6 but also directly produces apoptosis which is prevented by stem cell factor. Exp Hematol 32:911-7
Chung, Ik-Joo; Dai, Chunhua; Krantz, Sanford B (2003) Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells. Blood 101:1324-8
Xu, Ming-Jiang; Sui, Xingwei; Zhao, Runxiang et al. (2003) PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells. Blood 102:4354-60
Zhao, Runxiang; Fu, Xueqi; Li, Qingshan et al. (2003) Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine. J Biol Chem 278:22609-14
Dai, Chunhua; Chung, Ik-Joo; Jiang, Shazi et al. (2003) Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction. Br J Haematol 121:919-27
Ling, Jianhua; Pi, Wenhu; Bollag, Roni et al. (2002) The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol 76:2410-23
Zhao, Runxiang; Guerrah, Abdelmadjid; Tang, Hua et al. (2002) Cell surface glycoprotein PZR is a major mediator of concanavalin A-induced cell signaling. J Biol Chem 277:7882-8
Xu, Ming-jiang; Zhao, Runxiang; Cao, Hongxi et al. (2002) SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem Biophys Res Commun 293:1037-46
Qi, Ying; Zhao, Runxiang; Cao, Hongxi et al. (2002) Purification and characterization of protein tyrosine phosphatase PTP-MEG2. J Cell Biochem 86:79-89

Showing the most recent 10 out of 59 publications